Some individuals tolerate these changes without significant digestive symptoms, while others may notice bloating, constipation, or discomfort
Recent clinical evidence shows that semaglutide, a GLP-1 receptor agonist, preferentially reduces visceral fat deposits while preserving lean muscle mass
Contrave and Mental Health Bupropions dual nature: Approved antidepressant May improve mood in patients with depression Can help with smoking cessation Concerns: Black box warning for suicidal thoughts, particularly in young adults (under 24) May worsen anxiety in some patients Can trigger manic episodes in bipolar disorder Insomnia may affect mental health Who might benefit: Patients with comorbid depression who might benefit from bupropions mood effects Those with emotional eating tied to depression Who should be cautious: Young adults (increased suicidality risk) Patients with bipolar disorder Those with significant anxiety Semaglutide and Mental Health Generally neutral: Not designed to affect mood No antidepressant or anxiolytic properties No black box warning for suicidality Potential indirect benefits: Weight loss may improve mood and self-esteem Better physical health may support mental health Reduced food noise may reduce food-related anxiety Considerations: Some patients report improved mood with weight loss Rare reports of mood changes, but not systematic No specific concerns for most psychiatric conditions For Patients with Mental Health Conditions Depression: Contrave may provide dual benefit but requires careful monitoring
Measuring foods, weighing, counting (anything
Early in the year, shortages of the medication occurred as demand skyrocketed
If a smoker's melanosis is destroyed by excessive smoking, as in the hard palate of reverse smokers, who smoke with the glowing part of the cigarette inside the mouth for different reasons, a pale depigmented surface is first seen, indicating the loss of the protecting melanin
